Role of renal medullary oxidative and/or carbonyl stress in salt-sensitive hypertension and diabetes

Clinical and Experimental Pharmacology and Physiology

Volumn 39, Issue 1, 2012, Pages 125-131

  Mori, Takefumi ^a,b   Ogawa, Susumu ^a   Cowely, Allen W ^b   Ito, Sadayoshi ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Advanced glycation end products; Angiotensin II; Carbonyl substances; Hydrogen peroxide; Methylglyoxal; Superoxide

Indexed keywords

1,2 DICARBONYL DERIVATIVE; 8 HYDROXYDEOXYGUANOSINE; ACETYLCYSTEINE; ADVANCED GLYCATION END PRODUCT; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; APOCYNIN; DIETHYLDITHIOCARBAMIC ACID; DIPHENYLIODONIUM SALT; HYDROGEN PEROXIDE; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PROSTAGLANDIN F2 ALPHA; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; SUPEROXIDE; TEMPOL; THIAZIDE DIURETIC AGENT;

ALBUMINURIA; ARTICLE; BLOOD PRESSURE REGULATION; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; HENLE LOOP; HUMAN; HYPERTENSION; INSULIN RESISTANCE; KIDNEY BLOOD FLOW; KIDNEY CIRCULATION; KIDNEY INJURY; KIDNEY MEDULLA; KIDNEY STRUCTURE; KIDNEY TRANSPLANTATION; KIDNEY TUBULE ABSORPTION; NONHUMAN; OBESITY; OXIDATIVE STRESS; PATHOGENESIS; PROTEINURIA; RENOVASCULAR DISEASE; UREMIA;

ANIMALS; DIABETES MELLITUS; HUMANS; HYPERTENSION; KIDNEY MEDULLA; LOOP OF HENLE; NITRIC OXIDE; OXIDATIVE STRESS; PROTEIN CARBONYLATION; REACTIVE OXYGEN SPECIES; RENAL INSUFFICIENCY, CHRONIC; SODIUM CHLORIDE, DIETARY;

EID: 84855170973     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2011.05653.x     Document Type: Article

References (50)

1. Titze J, Ritz E. Salt and its effect on blood pressure and target organ damage: New pieces in an old puzzle. J. Nephrol. 2009; 22: 177-89.
2. Castiglioni P, Parati G, Brambilla L et al. Detecting sodium-sensitivity in hypertensive patients: Information from 24-hour ambulatory blood pressure monitoring. Hypertension 2011; 57: 180-5.
3. Dwivedi G, Beevers DG. Hypertension in ethnic groups: Epidemiological and clinical perspectives. Expert Rev. Cardiovasc. Ther. 2009; 7: 955-63.
4. Dahl LK, Heine M. Primary role of renal homografts in setting chronic blood pressure levels in rats. Circ. Res. 1975; 36: 692-6.
5. Wilcox CS, Welch WJ. TGF and nitric oxide. Effects of salt intake and salt-sensitive hypertension. Kidney Int. Suppl. 1996; 55: S9-13.
6. Cowley AW, Roman RJ, Fenoy FJ, Mattson DL. Effect of renal medullary circulation on arterial pressure. J. Hypertens. Suppl. 1992; 10: S187-93.
7. Evans RG, Majid DS, Eppel GA. Mechanisms mediating pressure natriuresis: What we know and what we need to find out. Clin. Exp. Pharmacol. Physiol. 2005; 32: 400-9.
8. Meng S, Roberts LJ II, Cason GW, Curry TS, Manning RD Jr. Superoxide dismutase and oxidative stress in Dahl salt-sensitive and -resistant rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002; 283: R732-8.
9. Mori T, Cowley AW Jr. Angiotensin II-NAD(P)H oxidase-stimulated superoxide modifies tubulovascular nitric oxide cross-talk in renal outer medulla. Hypertension 2003; 42: 588-93.
10. Taylor NE, Glocka P, Liang M, Cowley AW Jr. NADPH oxidase in the renal medulla causes oxidative stress and contributes to salt-sensitive hypertension in Dahl S rats. Hypertension 2006; 47: 692-8.
11. Meng S, Cason GW, Gannon AW, Racusen LC, Manning RD Jr. Oxidative stress in Dahl salt-sensitive hypertension. Hypertension 2003; 41: 1346-52.
12. Mori T, Polichnowski A, Glocka P et al. High perfusion pressure accelerates renal injury in salt-sensitive hypertension. J. Am. Soc. Nephrol. 2008; 19: 1472-82.
13. Chen YF, Cowley AW Jr, Zou AP. Increased H(2)O(2) counteracts the vasodilator and natriuretic effects of superoxide dismutation by tempol in renal medulla. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003; 285: R827-33.
14. 2 leads to hypertension. Hypertension 2003; 42: 25-30.
15. Makino A, Skelton MM, Zou AP, Roman RJ, Cowley AW Jr. Increased renal medullary oxidative stress produces hypertension. Hypertension 2002; 39: 667-72.
16. Mori T, Cowley AW Jr. Renal oxidative stress in medullary thick ascending limbs produced by elevated NaCl and glucose. Hypertension 2004; 43: 341-6.
17. Mori T, O'Connor PM, Abe M, Cowley AW Jr. Enhanced superoxide production in renal outer medulla of Dahl salt-sensitive rats reduces nitric oxide tubular-vascular cross-talk. Hypertension 2007; 49: 1336-41.
18. 2 on salt-induced hypertension and renal injury. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005; 289: R1573-9.
19. Zou AP, Li N, Cowley AW Jr. Production and actions of superoxide in the renal medulla. Hypertension 2001; 37: 547-53.
20. Feng MG, Dukacz SA, Kline RL. Selective effect of tempol on renal medullary hemodynamics in spontaneously hypertensive rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2001; 281: R1420-5.
21. Cowley AW Jr, Roman RJ, Kaldunski ML et al. Brown Norway chromosome 13 confers protection from high salt to consomic Dahl S rat. Hypertension 2001; 37: 456-61.
22. Cowley AW Jr, Stoll M, Greene AS et al. Genetically defined risk of salt sensitivity in an intercross of Brown Norway and Dahl S rats. Physiol. Genomics 2000; 2: 107-15.
23. Cowley AW Jr, Mori T, Mattson D, Zou AP. Role of renal NO production in the regulation of medullary blood flow. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003; 284: R1355-69.
24. Szentivanyi M Jr, Zou AP, Mattson DL et al. Renal medullary nitric oxide deficit of Dahl S rats enhances hypertensive actions of angiotensin II. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002; 283: R266-72.
25. Hu L, Manning RD Jr. Role of nitric oxide in regulation of long-term pressure-natriuresis relationship in Dahl rats. Am. J. Physiol. 1995; 268: H2375-83.
26. Gonzalez-Albarran O, Ruilope LM, Villa E, Garcia Robles R. Salt sensitivity: Concept and pathogenesis. Diabetes Res. Clin. Pract. 1998; 39 (Suppl.): S15-26.
27. Endo S, Mori T, Yoneki Y et al. Blockade of angiotensin II type-1 receptor increases salt sensitivity in Sprague-Dawley rats. Hypertens. Res. 2009; 32: 513-19.
28. Hall JE. Control of sodium excretion by angiotensin II Intrarenal mechanisms and blood pressure regulation. Am. J. Physiol. 1986; 250: R960-72.
29. Zou AP, Wu F, Cowley AW Jr. Protective effect of angiotensin II-induced increase in nitric oxide in the renal medullary circulation. Hypertension 1998; 31: 271-6.
30. Szentivanyi M Jr, Maeda CY, Cowley AW Jr. Local renal medullary l-NAME infusion enhances the effect of long-term angiotensin II treatment. Hypertension 1999; 33: 440-5.
31. Wu F, Park F, Cowley AW Jr, Mattson DL. Quantification of nitric oxide synthase activity in microdissected segments of the rat kidney. Am. J. Physiol. 1999; 276: F874-81.
32. Bankir L, de Rouffignac C. Urinary concentrating ability: Insights from comparative anatomy. Am. J. Physiol. 1985; 249: R643-66.
33. Rhinehart KL, Pallone TL. Nitric oxide generation by isolated descending vasa recta. Am. J. Physiol. Heart Circ. Physiol. 2001; 281: H316-24.
34. Park F, Mattson DL, Roberts LA, Cowley AW Jr. Evidence for the presence of smooth muscle alpha-actin within pericytes of the renal medulla. Am. J. Physiol. 1997; 273: R1742-8.
35. Dickhout JG, Mori T, Cowley AW Jr. Tubulovascular nitric oxide crosstalk: Buffering of angiotensin II-induced medullary vasoconstriction. Circ. Res. 2002; 91: 487-93.
36. Mori T, Cowley AW Jr, Ito S. Molecular mechanisms and therapeutic strategies of chronic renal injury Physiological role of angiotensin II-induced oxidative stress in renal medulla. J. Pharmacol. Sci. 2006; 100: 2-8.
37. Abe M, O'Connor P, Kaldunski M, Liang M, Roman RJ, Cowley AW Jr. Effect of sodium delivery on superoxide and nitric oxide in the medullary thick ascending limb. Am. J. Physiol. Renal Physiol. 2006; 291: F350-7.
38. Liang M, Berndt TJ, Knox FG. Mechanism underlying diuretic effect of l-NAME at a subpressor dose. Am. J. Physiol. Renal Physiol. 2001; 281: F414-19.
39. Ortiz PA, Garvin JL. Interaction of O(2)(-) and NO in the thick ascending limb. Hypertension 2002; 39: 591-6.
40. Ortiz PA, Garvin JL. Superoxide stimulates NaCl absorption by the thick ascending limb. Am. J. Physiol. Renal Physiol. 2002; 283: F957-62.
41. Nakayama K, Nakayama M, Iwabuchi M et al. Plasma alpha-oxoaldehyde levels in diabetic and nondiabetic chronic kidney disease patients. Am. J. Nephrol. 2008; 28: 871-8.
42. Miyata T, Ueda Y, Yamada Y et al. Accumulation of carbonyls accelerates the formation of pentosidine, an advanced glycation end product: Carbonyl stress in uremia. J. Am. Soc. Nephrol. 1998; 9: 2349-56.
43. Kumagai T, Nangaku M, Kojima I et al. Glyoxalase I overexpression ameliorates renal ischemia-reperfusion injury in rats. Am. J. Physiol. Renal Physiol. 2009; 296: F912-21.
44. Nakayama M, Saito K, Sato E et al. Radical generation by the non-enzymatic reaction of methylglyoxal and hydrogen peroxide. Redox Rep. 2007; 12: 125-33.
45. Guo Q, Mori T, Jiang Y et al. Methylglyoxal contributes to the development of insulin resistance and salt sensitivity in Sprague-Dawley rats. J. Hypertens. 2009; 27: 1664-71.
46. Ritz E. Metabolic syndrome and kidney disease. Blood Purif. 2008; 26: 59-62.
47. Ogawa S, Mori T, Nako K, Kato T, Takeuchi K, Ito S. Angiotensin II type 1 receptor blockers reduce urinary oxidative stress markers in hypertensive diabetic nephropathy. Hypertension 2006; 47: 699-705.
48. Ogawa S, Nako K, Okamura M, Senda M, Mori T, Ito S. Aliskiren reduces albuminuria and oxidative stress, and elevates glomerular filtration rates in Japanese patients with advanced diabetic nephropathy. Hypertens. Res. 2011; 34: 400-1.
49. Suzuki D, Miyata T, Saotome N et al. Immunohistochemical evidence for an increased oxidative stress and carbonyl modification of proteins in diabetic glomerular lesions. J. Am. Soc. Nephrol. 1999; 10: 822-32.
50. Ogawa S, Nakayama K, Nakayama M et al. Methylglyoxal is a predictor in type 2 diabetic patients of intima-media thickening and elevation of blood pressure. Hypertension 2010; 56: 471-6.